- Home
- REPL vs EMO Comparison
REPL vs EMO Comparison
Compare REPL & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- EMO
- Stock Information
- Founded
- REPL 2015
- EMO 2011
- Country
- REPL United States
- EMO United States
- Employees
- REPL N/A
- EMO N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- REPL Health Care
- EMO Finance
- Exchange
- REPL Nasdaq
- EMO Nasdaq
- Market Cap
- REPL 578.4M
- EMO 599.1M
- IPO Year
- REPL 2018
- EMO N/A
- Fundamental
- Price
- REPL $8.00
- EMO $44.93
- Analyst Decision
- REPL Strong Buy
- EMO
- Analyst Count
- REPL 6
- EMO 0
- Target Price
- REPL $20.00
- EMO N/A
- AVG Volume (30 Days)
- REPL 967.9K
- EMO 27.1K
- Earning Date
- REPL 05-15-2025
- EMO 01-01-0001
- Dividend Yield
- REPL N/A
- EMO 6.70%
- EPS Growth
- REPL N/A
- EMO N/A
- EPS
- REPL N/A
- EMO N/A
- Revenue
- REPL N/A
- EMO N/A
- Revenue This Year
- REPL $31.16
- EMO N/A
- Revenue Next Year
- REPL N/A
- EMO N/A
- P/E Ratio
- REPL N/A
- EMO N/A
- Revenue Growth
- REPL N/A
- EMO N/A
- 52 Week Low
- REPL $4.92
- EMO $26.42
- 52 Week High
- REPL $17.00
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- REPL 36.82
- EMO 45.02
- Support Level
- REPL $6.44
- EMO $40.04
- Resistance Level
- REPL $7.97
- EMO $43.95
- Average True Range (ATR)
- REPL 0.73
- EMO 2.18
- MACD
- REPL 0.08
- EMO -0.14
- Stochastic Oscillator
- REPL 41.47
- EMO 48.13
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.